Skip to main content
Open Access Publications from the University of California

Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring

  • Author(s): Brenner, M
  • Mahon, SB
  • Lee, J
  • Kim, J
  • Mukai, D
  • Goodman, S
  • Kreuter, KA
  • Ahdout, R
  • Mohammad, O
  • Sharma, VS
  • Blackledge, W
  • Boss, GR
  • et al.

Published Web Location Commons Attribution 4.0 International Public License

Our purpose is to compare cobinamide to hydroxocobalamin in reversing cyanide (CN)-induced physiologic effects in an animal model using diffuse optical spectroscopy (DOS). Cyanide poisoning is a major threat worldwide. Cobinamide is a novel molecule that can bind two molecules of cyanide, has a much higher binding affinity than hydroxocobalamin, and is more water soluble. We investigated the ability of equimolar doses of cobinamide and hydroxocobalamin to reverse the effects of cyanide exposure in an animal model monitored continuously by DOS. Cyanide toxicity was induced in 16 New Zealand white rabbits by intravenous infusion. Animals were divided into three groups: controls (n=5) received saline following cyanide, hydroxocobalamin (N=6) following cyanide, and cobinamide (N=5) following cyanide. Cobinamide caused significantly faster and more complete recovery of oxy-and deoxyhemoglobin concentrations in cyanide-exposed animals than hydroxocobalaminor saline-treated animals, with a recovery time constant of 13.8±7.1 min compared to 75.4±25.1 and 76.4±42.7 min, for hydroxocobalamin-and saline-treated animals, respectively (p<0.0001). This study indicates that cobinamide more rapidly and completely reverses the physiologic effects of cyanide than equimolar doses of cobalamin at the dose used in this study, and CN effects and response can be followed noninvasively using DOS. © 2010 Society of Photo-Optical Instrumentation Engineers.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View